Content area

|
|

Kirurgisk behandling af type 2-diabetes

Forfatter(e)
Reservelæge Stine Chabert Olesen, overlæge Dorte Lindqvist Hansen, overlæge Thomas Almdal, professor Flemming Bendtsen, overlæge Inge Nordgaard, overlæge Lisbeth Edvardsen Hvolris, professor Jens J. Holst, overlæge Lars Naver & professor Sten Madsbad Hvidovre Hospital, Endokrinologisk, Gastromedicinsk og Gastrokirurgisk Afdeling, og Københavns Universitet, Det Sundhedsvidenskabelige Fakultet, Biomedicinsk Institut
Reference: 
Ugeskr Læger 2009;171(8):615-617
Blad nummer: 
Sidetal: 
615-617
Summary Surgical treatment of diabetes mellitus Ugeskr Læger 2009;171(8):615-617 The resolution of diabetes after gastric bypass is already observed during the first days after the operation, while the control of diabetes after gastric banding occurs after weight loss. Other mechanisms than weight loss must therefore explain the improved glucose tolerance. Focus has been on appetite-regulating gut hormone, particularly peptide YY and glucagon-like peptide-1. Nevertheless, other unknown hormones or mechanisms may be involved in the dramatic changes in the glucose metabolism. Development of new drugs and treatments based on the endocrine changes observed after bariatric surgery with the aim of curing type 2-diabetes are warranted.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Andreas Gothardt Lundh | 02/12
1 Kommentar
af Michael Uldall Steinfath | 01/12
1 Kommentar
af Pedram Kazemi-Esfarjani | 01/12
1 Kommentar
af Bjarne Stigsby | 30/11
2 kommentarer
af Camilla Bang | 29/11
2 kommentarer
af Stine Madsen-Østerbye | 29/11
1 Kommentar
af Kaj Seidelin | 29/11
6 kommentarer
af Pedram Kazemi-Esfarjani | 28/11
2 kommentarer
af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer